ALR · Alerislife Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | - | - | $1.42B | $1.39B | $1.40B | $1.38B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $85.72M | $87.17M | $87.88M | $78.19M | $75.21M | $73.52M |
| Total Operating Expenses | $968.25M | $1.15B | $1.44B | $1.46B | $1.42B | $1.39B |
| D&A | $11.87M | $11.00M | $16.64M | $35.94M | $38.19M | $38.05M |
| Operating Income | ($25.86M) | $15.94M | ($20.27M) | ($71.56M) | ($23.05M) | ($15.97M) |
| Interest Expense | $1.68M | $1.63M | $2.62M | $3.02M | $4.31M | $4.91M |
| Income Tax | $234.0K | $663.0K | $56.0K | $247.0K | ($4.54M) | $2.35M |
| Net Income | ($7.59M) | ($7.59M) | ($20.00M) | ($74.08M) | ($20.90M) | ($21.81M) |
| EPS - Basic | ($0.24) | - | - | - | - | - |
| EPS - Diluted | ($0.24) | - | - | - | - | - |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $66.99M | $84.35M | $31.74M | $29.51M | $26.25M | $16.61M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $37.52M | - | - | - | - | - |
| Current Assets | $186.83M | $262.31M | $143.37M | $138.05M | $197.19M | $129.39M |
| Total Assets | $376.28M | $454.21M | $345.79M | $405.62M | $475.91M | $509.73M |
| Current Liabilities | $140.91M | $177.91M | $164.30M | $229.69M | $218.64M | $172.99M |
| Long-term Debt | - | - | - | - | $7.87M | $58.49M |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $181.59M | $210.53M | $119.98M | $71.17M | $144.99M | $164.27M |
| Retained Earnings | ($281.06M) | ($251.14M) | ($245.18M) | ($292.64M) | ($220.49M) | ($199.52M) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($7.57M) | $51.38M | ($54.22M) | ($54.22M) | $16.12M | ($23.45M) |
| Investing Cash Flow | ($7.65M) | $2.24M | $4.94M | $4.94M | $11.25M | $77.04M |
| Financing Cash Flow | ($1.44M) | ($1.01M) | $50.96M | $50.96M | ($18.72M) | ($51.65M) |
| CapEx | $9.44M | $5.43M | $57.49M | $48.98M | $71.09M | $55.42M |
| Free Cash Flow | ($17.01M) | $45.95M | ($111.72M) | ($103.20M) | ($54.98M) | ($78.87M) |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | - | - | -1.4% | -5.1% | -1.7% | -1.2% |
| EBITDA margin | - | - | -0.3% | -2.6% | 1.1% | 1.6% |
| Net margin | - | - | -1.4% | -5.3% | -1.5% | -1.6% |
| Free cash flow margin | - | - | -7.9% | -7.4% | -3.9% | -5.7% |
| FCF / Net income | 2.24 | -6.06 | 5.59 | 1.39 | 2.63 | 3.62 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | 6.2% | 5.6% | 5.4% | 5.3% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -2.0% | -1.7% | -5.8% | -18.3% | -4.4% | -4.3% |
| Return on equity | -4.2% | -3.6% | -16.7% | -104.1% | -14.4% | -13.3% |
| Return on invested capital | - | - | - | - | -11.9% | -5.7% |
| Liquidity | ||||||
| Current ratio | 1.33 | 1.47 | 0.87 | 0.60 | 0.90 | 0.75 |
| Quick ratio | 1.33 | 1.47 | 0.87 | 0.60 | 0.90 | 0.75 |
| Cash ratio | 0.48 | 0.47 | 0.19 | 0.13 | 0.12 | 0.10 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | 0.05 | 0.36 |
| Debt / Assets | - | - | - | - | 0.02 | 0.11 |
| Debt / EBITDA | - | - | - | - | 0.52 | 2.65 |
| Interest coverage | -15.4x | 9.8x | -7.8x | -23.7x | -5.4x | -3.3x |
| Equity multiplier | 2.07 | 2.16 | 2.88 | 5.70 | 3.28 | 3.10 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | - | - | 4.09 | 3.43 | 2.93 | 2.70 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | - | - | 1.8% | -0.4% | 1.3% | 0.9% |
| Revenue CAGR (3y) | - | - | 0.9% | 0.6% | 1.7% | 2.0% |
| Revenue CAGR (5y) | - | - | 1.3% | 1.4% | 0.7% | 3.8% |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | 71.7% | -210.4% | -44.3% | 56.9% |
| Net income growth (YoY) | 0.0% | 62.0% | 73.0% | -254.4% | 4.2% | 49.4% |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | -8.2% | -87.7% | 30.3% | -263.4% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -13.7% | 75.5% | 68.6% | -50.9% | -11.7% | -10.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$43.46M totalManagement Fees$43.46M · 100.0%
Stability scores
Piotroski F-score
FY 2021 · 9-point quality
1/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- -No share dilution
- -Gross margin improved
- -Asset turnover improved
Peer comparison
Same SIC group: Services-Skilled Nursing Care Facilities
Comparing AlerisLife Inc. against the 3 most active filers in the same SIC group.